From: MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer
Subtypes | The expression of Ki67 and hormonal status |
---|---|
Luminal A | Estrogen positive (ER +) |
Progesterone receptor (PR) ≥ 20% | |
HER2 negative (HER2-) | |
Ki67 < 14% | |
Luminal B (HER2−) | Estrogen positive (ER +) |
HER2 negative (HER2-) | |
Ki67 ≥ 20% | |
Progesterone receptor (PR) < 20% or progesterone receptor negative (PR-) | |
Luminal B (HER2+) | Any progesterone receptor (PR) level |
Any Ki67 level | |
HER2 positive (HER2+) | |
Estrogen positive (ER+) | |
HER2 positive (HER2+) (non-luminal) | HER2 positive (HER2+) |
Estrogen negative (ER-) | |
Progesterone negative (PR−) | |
Triple-negative breast cancer (TNBC) | HER2 negative (HER2−) |
Estrogen negative (ER−) | |
Progesterone negative (PR−) |